Source data for the manuscript "Chemoproteomics-driven discovery of a covalent inhibitor targeting Cys16 on RhoA in colorectal cancer"

Early Career Scheme (27315922) from University Grants Committee, and Seed Fund for Basic Research for New Staff (202009185025) and Enhanced New Staff Start-up Research Grant from the University Research Committee and Li Ka Shing Faculty of Medicine, The University of Hong Kong. This work was also supported by the Centre for Oncology and Immunology under the Health@InnoHK Initiative funded by the Innovation and Technology Commission, The Government of Hong Kong SAR, China.